BUSINESS
F&O Buzzer | Bulls continue to fuel the fire for Apollo Hospitals
Apollo Hospitals has surpassed its 200-day exponential moving average along with a 150 percent jump in volumes, which reflects the underlying strength in its upward momentum.
BUSINESS
Analyst Call Tracker: Why are analysts lowering expectations from HCL Technologies?
HCL Tech, which has a fairly sizeable exposure to the troubled BFSI segment in key US and Europe markets, is likely to report a drop in constant currency revenue growth in a seasonally weak fourth quarter. Its consistent underperformance is also a worrying factor.
BUSINESS
Max Healthcare Institute hits 52-week high following large deal
Max Healthcare finally ended 6.23 percent higher at Rs 479 on the National Stock Exchange
BUSINESS
Improved sentiment, hopes of better sales fuel gains in pharma stocks; Divi's Lab spurts 8%
Multiple counters in the pharmaceutical space, including Divi's Laboratories, Cipla, Sun Pharmaceuticals, Lupin, and Natco Pharma also witnessed large deals on April 12.
BUSINESS
Analyst Call Tracker: Bullish calls on RIL rise as risk-reward ratio improves
Analysts are optimistic about the stock because they say valuations have become attractive after the recent correction in stock price. Most of the company's near-term negatives are already priced in, they say.
BUSINESS
Neogen Chemicals spurts 6% on pact with Japanese major for electrolyte solutions
The agreement will enable Neogen Chemicals to capitalize on the growing demand of lithium-ion batteries in India.
BUSINESS
F&O Manual | Nifty likely to consolidate, analysts suggest going short
The market opened on a positive footing and even managed to extend gains through the session. However, some profit booking in the last hour of trade saw the Nifty pare much of its gains to end marginally higher.
BUSINESS
JLR wholesale numbers for Jan-Mar drive Tata Motors shares to 7-month high
Global research and broking firm, Goldman Sachs upgraded the stock to "buy", citing improved volume outlook for the company's luxury arm JLR. The broking firm sees an upside potential of over 24 percent for Tata Motors.
BUSINESS
Goldman downgrades Maruti Suzuki to 'neutral' on slowing demand for small cars
Goldman Sachs lowers the target price for the Maruti Suzuki stock by 20 percent to to Rs 8,800 after domestic sales declined in March to 139,952 units, down from 143,899 units a year ago
BUSINESS
Be Patient: Jefferies sees regulatory snags as buying opportunity in hospital stocks
Despite near-term jitters, hospital operators are undertaking massive capex, not just to expand their offerings but also to add more beds and improve occupancy.
BUSINESS
Angel One shares rise 3% as client base grows on month in March
Angel One managed to expand its overall equity retail turnover market share by 120 basis points from the previous month to 23.8 percent
BUSINESS
Contrarian Calls | Tech Mahindra's management rejig stirs analysts' optimism despite weak price action
Despite concerns over underperformance in near term, a management rejig at Tech Mahindra gave way for some positive views from analysts.
BUSINESS
M&M shares rise as automaker posts highest ever auto sales in March
For FY23, the automaker saw a 59 percent jump in total sales of passenger vehicles which stood at 359,253 units as against FY22's 225,895 units.
BUSINESS
Ashok Leyland shares gain on robust monthly sales
Brokerage firm ICICIdirect believes the growth in medium and heavy commercial vehicle segment was particularly strong as the bus segment came out of the woods post the slump witnessed over last few years.
BUSINESS
Three pharma stocks heal the pain with up to 16% returns, boost hopes for more
Analysts have identified a common factor among the three firms that prompted investors to lap up their shares — their relatively low valuations over the past few months.
BUSINESS
Lupin shares slip as US FDA issues ten observations for Pithampur unit
Lupin's Pithampur plant also holds significance for the company as it plans to manufacture the generic of Spiriva at the facility. Spiriva is a prescription drug that is used long term to improve breathing in people with certain respiratory conditions.
BUSINESS
MPP signs supply pact with Aurobindo Pharma, Cipla and Viatris for HIV drug
This agreement also gains significance of being the first instance when longer-acting injectable products for HIV prevention are being made available to low and middle-income countries.
BUSINESS
Nirmal Bang sees 25% upside in this speciality chemicals stock. Here’s why
SRF’s superior operating metrics compared to competitors and pharma companies, the global trend of countries seeking alternative supply opportunities outside of China, making India an option thanks to its relevant skillsets, and the heavy investment by India's specialty chemicals companies in expanding their capabilities, are reasons for the bullishness in this stock.
BUSINESS
F&O Manual: Nifty may sustain gains, F&O expiry likely around 17,100
All sectoral indices traded with gains which suggests that their is an overall recovery in the market.
BUSINESS
Mphasis shares rise on clarification of no exposure to collapsed US banks
In addition, a large deal involving 6.48 lakh shares or a 0.35 percent stake in the company also took place on the bourses today.
BUSINESS
Know your stock | Is Eris Lifesciences on the verge of a turnaround?
Eris Lifesciences has been on an acquisition spree in a bid to diversify its offerings. The company recently bought nine dermatology brands from both Dr Reddy’s Laboratories and Glenmark Pharma.
BUSINESS
F&O Manual: Analysts see some pullback in Nifty ahead of expiry tomorrow
Analysts expect the Nifty to face an immediate resistance at 17,200 whereas support is seen around 16,900.
BUSINESS
F&O Manual: Volatility takes over Nifty, traders remain bearish
Most sectoral indices traded with cuts which suggests that the bearish pressure was largely broad based.
BUSINESS
F&O Manual: Bearish sentiment to continue, analysts suggest sell on rise
Put as well as call writers were most active at 17,000 strike price options.
